Skip to main navigation Skip to search Skip to main content

A Long-Term, Non-Interventional Registry to Assess Safety and Effectiveness of Humira (Adalimumab) in Pediatric Patients with Moderatly to Severly Active Crohn's Disease (CD) - CAPE

Project: Research

Project Details

StatusFinished
Effective start/end date10/19/15 → 10/18/24

Funding

  • AbbVie Incorporated: $105,931.54